Jesse Baumgartner is a Licensing Manager in the Office of Technology Development. He joined Memorial Sloan Kettering in 2016.
Previously, Jesse served as a Senior Associate at Stern Investor Relations, where he worked extensively with private and public biotech companies, providing investor relations and strategic communications consulting. He has deep knowledge of the biotech industry, with experience monitoring a wide variety of competitive therapeutic areas. Jesse is a graduate of the University of North Carolina at Chapel Hill, and he is a CFA charterholder.